Evidence map›Paper›PMID 22585341›Full record

ReviewThe Neuroscientist : a review journal bringing neurobiology, neurology and psychiatry2012

N-acetylserotonin: neuroprotection, neurogenesis, and the sleepy brain.

Gianluca Tosini, Keqiang Ye, P Michael Iuvone

Abstract readReview
In one paragraph

Review in The Neuroscientist : a review journal bringing neurobiology, neurology and psychiatry, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 24 papers.

0numbers the graph read from it
0cells of the map it votes in
24citing papers in PubMed
2.2field-weighted citation impact, top 12% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

24 citing papers in PubMed, 63 citations in OpenAlex.

  1. Review
  2. Article
  3. Review
  4. Article
  5. Review
  6. Article
  7. Review
  8. Article
  9. Article
  10. Review
  11. Insect ArylalkylamineFrontiers in molecular biosciences · 2018
    Review
  12. Review
  13. Review
  14. Article
  15. The Retina and Other Light-sensitive Ocular Clocks.Journal of biological rhythms · 2016
    Review
  16. Article
  17. Review
  18. Review
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 2 institutions in 1 country.

Gianluca TosiniMorehouse School of Medicine, Atlanta, GA 30310, USA. gtosini@msm.edu
Keqiang Ye
P Michael Iuvone
Emory University · USMorehouse School of Medicine · US

Funding

P30-Core Grant for Vision Research Core CP30EY006360 · NEI · EMORY UNIVERSITY · PI BOATRIGHT, JEFFREY H · 1986 to 2025
$15.3M
Neuromodulators and Circadian Clocks: Roles in Retinal Function and DysfunctionR01EY004864 · NEI · EMORY UNIVERSITY · PI IUVONE, P MICHAEL · 1985 to 2018
$7.0M
Photic and Circadian Regulation of Retinal MelatoninR01NS043459 · NINDS · MOREHOUSE SCHOOL OF MEDICINE · PI TOSINI, GIANLUCA · 2003 to 2010
$2.3M
Molecular Regulation and Biological Functions of PIKE-AR01CA127119 · NCI · EMORY UNIVERSITY · PI YE, KEQIANG · 2008 to 2012
$1.6M
Photic and Circadian Regulation of Retinal MelatoninR01EY022216 · NEI · MOREHOUSE SCHOOL OF MEDICINE · PI TOSINI, GIANLUCA · 2012 to 2015
$1.4M
Neuromodulators and Signaling Cascades in RetinaR01EY014764 · NEI · EMORY UNIVERSITY · PI IUVONE, P MICHAEL · 2004 to 2007
$1.4M
Circadian Regulation of the PER2::LUC Bioluminescence Rhythm in the Mouse RPER21EY020821 · NEI · MOREHOUSE SCHOOL OF MEDICINE · PI TOSINI, GIANLUCA · 2010 to 2011
$382k
Photic and circadian regulation of retinal melatoninR56NS043459 · NINDS · MOREHOUSE SCHOOL OF MEDICINE · PI TOSINI, GIANLUCA · 2011 to 2011
$368k
NCI NIH HHS R01 CA127119NEI NIH HHS P30 EY006360NEI NIH HHS R01 EY004864NEI NIH HHS R01 EY014764NEI NIH HHS R01 EY022216NEI NIH HHS R21 EY020821NEI NIH HHS R21 EY028821NINDS NIH HHS R01 NS043459NINDS NIH HHS R01 NS43459NINDS NIH HHS R56 NS043459
6 · The paper itself

Abstract

N-Acetylserotonin (NAS) is a naturally occurring chemical intermediate in biosynthesis of melatonin. Previous studies have shown that NAS has different brain distribution patterns from those of serotonin and melatonin, suggesting that NAS might have functions other than as a precursor or metabolite of melatonin. Indeed, several studies have now shown that NAS may play an important role in mood regulation and may have antidepressant activity. Additional studies have shown that NAS stimulates proliferation of neuroprogenitor cells and prevents some of the negative effects of sleep deprivation. It is believed that the antidepressant and neurotrophic actions of NAS are due at least in part to the capability on this molecule to activate the TrkB receptor in a brain-derived neurotrophic factor-independent manner. Emerging evidence also indicates that NAS and its derivatives have neuroprotective properties and protect retinal photoreceptor cells from light-induced degeneration. In this review, the authors discuss the literature about this exciting and underappreciated molecule.

Indexed as

AnimalsBrainHumansNeurogenesisNeuroprotective AgentsSerotoninSleepN-acetylserotoninNeuroprotective AgentsSerotonin

Identifiers

PMID22585341
PMCPMC3422380
OpenAlexW2119749975

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.